Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation.
Hashim AliMiguel ManoLuca BragaAsma NaseemBruna MariniDiem My VuChiara CollesiGermana MeroniMarina LusicMauro GiaccaPublished in: Nature communications (2019)
Productive HIV-1 replication requires viral integrase (IN), which catalyzes integration of the viral genome into the host cell DNA. IN, however, is short lived and is rapidly degraded by the host ubiquitin-proteasome system. To identify the cellular factors responsible for HIV-1 IN degradation, we performed a targeted RNAi screen using a library of siRNAs against all components of the ubiquitin-conjugation machinery using high-content microscopy. Here we report that the E3 RING ligase TRIM33 is a major determinant of HIV-1 IN stability. CD4-positive cells with TRIM33 knock down show increased HIV-1 replication and proviral DNA formation, while those overexpressing the factor display opposite effects. Knock down of TRIM33 reverts the phenotype of an HIV-1 molecular clone carrying substitution of IN serine 57 to alanine, a mutation known to impair viral DNA integration. Thus, TRIM33 acts as a cellular factor restricting HIV-1 infection by preventing provirus formation.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- human immunodeficiency virus
- hiv testing
- hiv aids
- hepatitis c virus
- single molecule
- men who have sex with men
- sars cov
- cell free
- circulating tumor
- high throughput
- induced apoptosis
- stem cells
- oxidative stress
- genome wide
- single cell
- cell death
- cell proliferation
- mesenchymal stem cells
- cell cycle arrest
- optical coherence tomography
- drug delivery
- mass spectrometry
- signaling pathway